| Sign-up pace much slower in week 4 of 2018 Obamacare enrollment | | | NEW YORK (Reuters) - The pace of people signing up for individual insurance under Obamacare slowed significantly during the fourth week of 2018 enrollment, as nearly 37 percent fewer people signed up for the healthcare plans than in the previous week, a U.S. government agency reported on Wednesday. |
| |
| FDA moves to speed nicotine replacement product development | | | (Reuters) - The U.S. Food and Drug Administration said on Wednesday it is considering measures to speed development of products that help people quit smoking, including easing requirements for approval of over-the-counter nicotine replacement therapies. |
| |
| U.S. says patient charity helped drugmakers, revokes approval | | | (Reuters) - One of the largest U.S. patient assistance charities may close after the federal government revoked its authorization, citing findings that the group, mainly funded by pharmaceutical companies, enabled drugmakers to influence prescriptions. |
| |
| Sanofi expects $120 million hit as dengue vaccine hits major snag | | | PARIS (Reuters) - Use of Sanofi's dengue vaccine, the world's first approved shot against the mosquito-borne virus, is to be strictly limited due to evidence it can worsen the disease in people who have not previously been exposed to the infection. The French drugmaker said in a statement on Wednesday that as a result it would book a charge in its fourth-quarter results of around 100 million euros ($118.57 million). |
| |
| Health secretary nominee Azar says lowering drug prices a top priority | | | WASHINGTON (Reuters) - Alex Azar, a former drug industry executive and lobbyist nominated to run the U.S. Department of Health and Human Services, promised on Wednesday to lower drug prices and said he was unaware of any efforts to sabotage the healthcare law passed under former President Barack Obama. |
| |
| | |
